The effects of neonicotinoid insecticides on female reproductive health
Neonicotinoid insecticides and female reproduction
This study looks at how a common insecticide called Imidacloprid might affect women's reproductive health by potentially causing problems in the ovaries, and it's designed for anyone interested in understanding the risks of everyday agricultural chemicals.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-10936899 on NIH RePORTER |
What this research studies
This research investigates how exposure to neonicotinoid insecticides, particularly Imidacloprid, affects female reproductive health. It focuses on the potential bioactivation of this insecticide in the ovaries, leading to the production of a more toxic compound that may disrupt normal follicle growth and hormone production. The study will involve laboratory experiments to assess the impact of this compound on ovarian function and reproductive outcomes. By understanding these effects, the research aims to highlight the risks associated with common agricultural chemicals.
Who could benefit from this research
Good fit: Ideal candidates for this research are adult women who may have been exposed to neonicotinoid insecticides through food, water, or environmental contact.
Not a fit: Patients who are not adult women or those who have not been exposed to neonicotinoids may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of reproductive health risks associated with agricultural chemicals in women.
How similar studies have performed: While the specific focus on neonicotinoids and female reproduction is relatively novel, there is growing evidence linking agricultural chemicals to reproductive health issues in other studies.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Flaws, Jodi a. — University of Illinois at Urbana-Champaign
- Study coordinator: Flaws, Jodi a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.